![Ray Takigiku](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ray Takigiku
Direttore/Membro del Consiglio presso
Sidis Corp
Profilo
Ray Takigiku was the founder of Bexion Pharmaceuticals, Inc., founded in 2006, and held the title of Chief Scientific Officer from 2022 to 2024.
Dr. Takigiku currently holds the position of Director at Sidis Corp.
Posizioni attive di Ray Takigiku
| Società | Posizione | Inizio |
|---|---|---|
Sidis Corp
 Sidis Corp Financial ConglomeratesFinance Provides investment services for market-leading life science companies | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Ray Takigiku
| Società | Posizione | Fine |
|---|---|---|
Bexion Pharmaceuticals, Inc.
 Bexion Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovering and developing drugs for curing cancer | Amministratore Delegato | 02/02/2022 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
1
Relazioni di 1° grado
2
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Bexion Pharmaceuticals, Inc.
Bexion Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovering and developing drugs for curing cancer | Commercial Services |
Sidis Corp
Sidis Corp Financial ConglomeratesFinance Provides investment services for market-leading life science companies | Finance |
